You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 279 No. 15, April 15, 1998 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (52)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Evidence-Based Medicine
 •Alert me on articles by topic

Drugs and Adverse Drug Reactions

How Worried Should We Be?

David W. Bates, MD, MSc

JAMA. 1998;279:1216-1217.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Physicians can hardly pick up a medical journal or a newspaper today without reading about some new medication, and how it promises to completely change the course of a disease or relieve some troublesome symptom. Indeed, the wonders of pharmacology are numerous. It is clear, for example, that after a myocardial infarction patients will live longer if they take {beta}-blockers 1 and that patients with congestive heart failure live longer and feel better when they take angiotensin-converting enzyme inhibitors.2 However, medications are a double-edged sword.

Much of the recent work on problems with medications has focused primarily on errors in medication use, which are important.3 But, adverse drug reactions (ADRs) that are not preventable given our current state of knowledge are a more common problem, with a greater human burden. In this issue of JAMA, Lazarou and colleagues4 attempt to assess the extent of this . . . [Full Text of this Article]

From the Deparment of Clinical and Quality Analysis, Partners Healthcare Systems, Boston, Mass.


RELATED ARTICLE

Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-analysis of Prospective Studies
Jason Lazarou, Bruce H. Pomeranz, and Paul N. Corey
JAMA. 1998;279(15):1200-1205.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Can Surveillance Systems Identify and Avert Adverse Drug Events? A Prospective Evaluation of a Commercial Application
Jha et al.
J. Am. Med. Inform. Assoc. 2008;15:647-653.
ABSTRACT | FULL TEXT  

Evaluation of Outpatient Computerized Physician Medication Order Entry Systems: A Systematic Review
Eslami et al.
J. Am. Med. Inform. Assoc. 2007;14:400-406.
ABSTRACT | FULL TEXT  

Pitfalls in the Management of Angina in the Elderly
Futterman and Lemberg
Am J Crit Care 2007;16:184-186.
FULL TEXT  

National surveillance of emergency department visits for outpatient adverse drug events.
Budnitz et al.
JAMA 2006;296:1858-1866.
ABSTRACT | FULL TEXT  

Adverse Drug Reactions and Avalanches: Life at the Edge of Chaos
Frattarelli
J Clin Pharmacol 2005;45:866-871.
ABSTRACT | FULL TEXT  

Best practices for safe handling of products containing concentrated potassium
Tubman et al.
BMJ 2005;331:274-277.
FULL TEXT  

Drug safety without borders: concerns about bupropion
Mintzes et al.
CMAJ 2002;167:447-447.
FULL TEXT  

Adverse Reactions to Antidepressants in Consultation-Liaison Psychiatry Inpatients
Smith et al.
Psychosomatics 2002;43:228-233.
ABSTRACT | FULL TEXT  

Recent Patterns of Medication Use in the Ambulatory Adult Population of the United States: The Slone Survey
Kaufman et al.
JAMA 2002;287:337-344.
ABSTRACT | FULL TEXT  

Drug-Related Deaths in a Department of Internal Medicine
Ebbesen et al.
Arch Intern Med 2001;161:2317-2323.
ABSTRACT | FULL TEXT  

Using Computerized Data to Identify Adverse Drug Events in Outpatients
Honigman et al.
J. Am. Med. Inform. Assoc. 2001;8:254-266.
ABSTRACT | FULL TEXT  

Methodological and Motivational Factors Affecting the Surveillance of Adverse Events in Hospitalized Patients
Maistrello et al.
American Journal of Medical Quality 2001;16:107-109.
ABSTRACT  

Dose Discrepancies Between the Physicians' Desk Reference and the Medical Literature, and Their Possible Role in the High Incidence of Dose-Related Adverse Drug Events
Cohen
Arch Intern Med 2001;161:957-964.
ABSTRACT | FULL TEXT  

Drug Interactions in Palliative Care
Bernard and Bruera
JCO 2000;18:1780-1799.
ABSTRACT | FULL TEXT  

Adverse Drug Reactions in Hospitalized Patients
Fremont-Smith et al.
JAMA 1998;280:1741-1741.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.